30 July 2026 - Stevanato Group S.p.A. (NYSE:STVN), a provider of drug containment, drug delivery and diagnostic solutions for the pharmaceutical, biotechnology and life sciences industries, announced on Thursday that liraglutide-based combination pro...
30 July 2026 - US biopharmaceutical company Pfizer Inc (NYSE:PFE) on Thursday announced positive topline results from two Phase 3 trials evaluating LITFULO (ritlecitinib) as a potential oral systemic therapy for patients with nonsegmental vitiligo (N...
30 July 2026 - Switzerland-based plasma fractionator Octapharma on Wednesday announced plans to establish its first-ever US-based manufacturing and production site at the Palmetto Research Park in Rock Hill, South Carolina.The USD1.5bn project is exp...
30 July 2026 - Ractigen Therapeutics, a clinical-stage biotechnology company developing small activating RNA (saRNA) therapeutics and advanced extrahepatic delivery systems, announced on Wednesday the successful closing of a new financing round excee...
30 July 2026 - Life science technology company 10x Genomics Inc (Nasdaq:TXG) on Wednesday announced a research collaboration with Lausanne University Hospital (CHUV), a Swiss academic medical centre, to advance research in diagnostic applications of ...